North Korea has rejected planned shipments of AstraZeneca’s COVID-19 vaccine that were being organized under the global COVAX distribution scheme due to concerns over side effects, a South Korean think-tank said on Friday. COVAX has said it would provide nearly 2 million doses of AstraZeneca’s shots to North Korea.
